FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Dementia toolkit for clinicians underscores urgency of early diagnosis
By
Alicia Lasek
Mar 31, 2021
A primary care toolkit for brain health assessment and dementia diagnosis has gotten a much-needed update as more research points to the potential for better outcomes with earlier diagnoses, the authors...
OIG: Older Medicare recipients often harmed during hospital stays
May 13, 2022
Fully 25% of older American Medicare beneficiaries are at high risk of being harmed during acute care stays, according to the HHS Office of the Inspector General.
Pandemic bump in antipsychotics use raises questions about long-term care outcomes
By
Danielle Brown
Apr 12, 2022
The findings raise questions about the short- and long-term effects on the quality of care and health outcomes for residents, the authors say.
LTC docs push for more training, competency requirements for medical directors
By
Alicia Lasek
Apr 11, 2022
It’s time for Congress and CMS to take action and raise the profile and competencies of industry clinicians — especially medical directors, according to long-term care physician advocate AMDA.
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Staff concerns a sign that restraints may be overused, researchers say
By
Alicia Lasek (f3)
Apr 21, 2022
Residents are more likely to be restrained in nursing homes where staff members report inappropriate use of these tools, a new study finds.
Lawmakers push FDA to take swift action on OTC hearing aids
By
Diane Eastabrook
Apr 12, 2022
A bipartisan team has introduced a bill that orders the FDA to stop dragging its feet and issue a final rule making over-the-counter hearing aids available to consumers.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Cannabis-related issues sending more seniors to the ED, study finds
By
Alicia Lasek
Jan 12, 2023
Cannabis-related ED visits for older adults shot up by a whopping 1,800% between 2005 to 2019 in California, investigators say. The state’s experience mirrors national trends.